Latvian national focal point
The national focal point is located in Centre for Disease Prevention and Control of Latvia. The Centre for Disease Prevention and Control of Latvia is a newly established public institution responsible for data collection and monitoring on different public health issues.
News
Events, meetings and visits
- Coming soon: European Drug Report 2024 to be released on 11 June
- Celebrating European Day of Languages: EMCDDA multilingual drug glossary unveiled
- Reitox network meets to showcase 2022 highlights, new digital resources and plan future activities
- 25 years of early warning and response to new psychoactive substances in Europe
- Penalties for drug law offences in Europe ‘at a glance’ — new countries added to online tool
- EMCDDA launches 2021 European Web Survey on Drugs to assess patterns of drug use in over 30 countries
Events
Events, meetings and visits
- 69th Reitox extended meeting (21.11.2023 to 23.11.2023, )
- Expert meeting on drug-related infectious diseases (DRID) 2023 (30.10.2023 to 31.10.2023, Lisbon, Portugal)
- Expert meeting on drug-related deaths (DRD) 2023 (10.10.2023 to 11.10.2023, Lisbon, Portugal)
- 67th Heads of Reitox national focal points meeting (28.11.2022 to 30.11.2022, )
- 9th Extended Reitox network meeting (24.11.2020, Online)
- National Reitox Academy New Psychoactive Substances (24.01.2019, Vilnius, Lithuania)
Publications
Publications related to this partner
Despite a continued decline in injecting drug use over the past decade in Europe, this behaviour is still responsible for a disproportionate level of health harms. On this page, you can find the latest analysis of injecting drug use in Europe, including key data on prevalence at nationa
People who inject drugs are at risk of contracting infections through the sharing of drug use paraphernalia. On this page, you can find the latest analysis of drug-related infectious diseases in Europe, including key data on infections with HIV and hepatitis B and C viruses.
Drug-induced deaths are those that are directly attributable to the use of drugs. On this page, you can find the latest analysis of drug-induced deaths in Europe, including key data on overdose deaths, substances implicated and more.
Opioid users represent the largest group undergoing specialised drug treatment, mainly in the form of opioid agonist treatment.
Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. On this page, you can find the latest analysis of harm reduction interventions in Europe, including key data on o
Drug supply, production and precursors – the current situation in Europe (European Drug Report 2023)
An analysis of the supply-related indicators available on the commonly used illicit drugs in the European Union suggests that availability remains high across all substance types. On this page, you can find an overview of drug supply in Europe based on the latest data, supported by the lates
Document library
Relevant external documents or commissioned reports from the EMCDDA Document library
- Final Draft MEETING REPORT 2nd meeting on detecting and responding to outbreaks of HIV among people who inject drugs ( )
- Conclusions of the 39th meeting of Reitox Heads of Focal Points ( )
- Conclusions of the 40th meeting of Reitox Heads of Focal Points ( )
- Conclusions of the 41st meeting of Reitox Heads of Focal Points ( )
- Conclusions of the 42nd meeting of Reitox Heads of Focal Points ( )
- Final conclusions 43rd Reitox Heads of Focal Points meeting ( )
Media library
Related photos, infographics and videos from our Media library
Contact information
Centre for Disease Prevention and Control of Latvia
Ms Ieva Pugule
Riga
Latvia